Cerdulatinib
|
賽度替尼
|
1198300-79-6
|
SR8278
|
SR8278;SR-8278;SR 8278
|
1254944-66-5
|
DazoxibenHCl
|
UK-37248
|
74226-22-5
|
FT113
|
FT113
|
1630808-89-7
|
TH 5487
|
TH 5487
|
2304947-71-3
|
PF 05105679
|
PF 05105679
|
1398583-31-7
|
CGP60474
|
3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇
|
164658-13-3
|
SR9009
|
SR9009
|
1379686-30-2
|
GSK3787
|
GSK-3787
|
188591-46-0
|
VUN65671
|
VUN65671
|
2479465-67-1
|
PKC-iota inhibitor 1
|
2-氨基-5-(3-(哌嗪-1-基)苯基)-N-(吡啶-4-基)煙酰胺
|
2328094-11-5
|
SCH 546738
|
3-氨基-6-氯-5-[(3S)-4-[1-[(4-氯苯基)甲基]-4-哌啶基]-3-乙基-1-哌嗪基]-2-哌嗪甲酰胺
|
906805-42-3
|
FB23
|
FB23
|
2243736-35-6
|
MS049 2HCl
|
MS049 (hydrochloride)
|
2095432-59-8
|
BI-605906
|
化合物 T14567
|
960293-88-3
|
iGOT1-01
|
化合物IGOT1-01
|
882256-55-5
|
PZ-2891
|
PZ-2891
|
2170608-82-7
|
YF-2
|
YF-2
|
1311423-89-8
|
APS-2-79
|
APS-2-79 鹽酸鹽
|
2002381-31-7
|
ETC-159
|
1,2,3,6-四氫-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-噠嗪基)-7H-嘌呤-7-乙酰胺
|
1638250-96-0
|
APS-2-79
|
2002381-25-9
|
2002381-25-9
|
SC-236
|
4-(5-(4-氯苯基)-3-(三氟甲基)-1H-
|
170569-86-5
|
BRD4770
|
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯
|
1374601-40-7
|
NCGC00378430
|
|
|
3-methyl-N-(3-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)-1,2-oxazole-5-carboxamide
|
T5601640
|
924473-59-6
|
N-(4-Chlorophenyl)-4-(1H-indol-4-yl)piperazine-1-carboxamide
|
N-(4-氯苯基)-4-(1H-吲哚-4-基)哌嗪-1-甲酰胺
|
732973-87-4
|
BX-430
|
BX 430
|
688309-70-8
|
UNC-926
|
UNC-926
|
1184136-10-4
|
GJ-103
|
J103 游離
|
1459687-89-8
|
SLV-2436
|
2095704-43-9
|
2095704-43-9
|
S C 707
|
N-6-異喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲
|
1687736-54-4
|
UT-34
|
UT-34
|
2168525-92-4
|
Insulin-like Growth Factor-1 Receptor Inhibitor
|
胰島素樣生長因子-1 受體拮抗劑
|
468740-43-4
|
Orelabrutinib
|
奧布替尼
|
1655504-04-3
|
Pexmetinib
|
PEXMETINIB
|
945614-12-0
|
Takinib
|
1111556-37-6
|
1111556-37-6
|
TCN-201
|
TCN-201
|
852918-02-6
|
ML418
|
ML418
|
1928763-08-9
|
RU-302
|
RU-302
|
1182129-77-6
|
ML335
|
化合物ML335
|
825658-06-8
|
Eliprodil (SL-820715)
|
依利羅地
|
119431-25-3
|
NAcM-OPT
|
化合物NACM-OPT
|
2089293-61-6
|
VU6015929
|
VU6015929
|
|
ASP7663
|
ASP 7663;ASP-7663;ASP7663
|
1190217-35-6
|
CDPPB
|
3-氰基-N-(1,3-二苯基吡唑-5-基)苯甲酰胺
|
781652-57-1
|
2,4-Dichloro-N-(phenylcarbamoyl)phenylbenzamide
|
CID-1375606
|
313493-80-0
|
SKLB 610
|
SKLB610
|
1125780-41-7
|
VU-29
|
VU-29
|
890764-36-0
|
SB4
|
SB 4
|
100874-08-6
|
SJ000291942
|
SJ000291942
|
425613-09-8
|
LDC000067
|
(3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺
|
1073485-20-7
|
TAK-632
|
TAK-632
|
1228591-30-7
|
AZ 628
|
AZ 628
|
878739-06-1
|
GNE-617
|
N-[[4-[(3,5-二氟苯基)磺?;鵠苯基]甲基]咪唑并[1,2-A]吡啶-6-甲酰胺
|
1362154-70-8
|
865285-29-6
|
865285-29-6
|
865285-29-6
|
SKLB-23bb
|
SKLB-23bb
|
1815580-06-3
|
NS 11394
|
3'-[5-(1-羥基-1-甲基乙基)-1H-苯并咪唑-1-基]-[1,1'-聯(lián)苯]-2-甲腈
|
951650-22-9
|
HS-173
|
HS-173
|
1276110-06-5
|
ETC-206
|
4-[6-[4-(4-嗎啉基羰基)苯基]咪唑并[1,2-A]吡啶-3-基]芐腈
|
1464151-33-4
|
GK921
|
1025015-40-0
|
1025015-40-0
|
Benzamide, 3-(dimethylamino)-N-[3-[(4-hydroxybenzoyl)amino]-4-methylphenyl]-
|
ZM 336372
|
208260-29-1
|
Kartogenin
|
2-([1,1-聯(lián)苯]-4-基氨基甲酰)苯甲酸
|
4727-31-5
|
AGI6780
|
AGI-6780
|
1432660-47-3
|
DB-07268
|
2-[[2-[(3-羥基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺
|
929007-72-7
|
UBCS039
|
UBCS039
|
358721-70-7
|
KY 02111
|
KY 02111
|
1118807-13-8
|
RU-301
|
RU-301
|
1110873-99-8
|
EI1
|
6-氰基-N-[(1,2-二氫-4,6-二甲基-2-氧代-3-吡啶基)甲基]-1-(1-乙基丙基)-1H-吲哚-4-甲酰胺
|
1418308-27-6
|
WM-1119
|
化合物WM-1119
|
2055397-28-7
|
ML417
|
ML417
|
1386162-69-1
|
LIT-001
|
化合物LIT-001
|
2245072-21-1
|
VPS34 inhibitor 1
|
VPS34
|
1383716-46-8
|
ML216
|
N-[4-氟-3-(三氟甲基)苯基]-N'-[5-(4-吡啶基)-1,3,4-噻二唑-2-基]脲
|
1430213-30-1
|
BC-DXI-843
|
化合物BC-DXI-843
|
2421117-98-6
|
JNJ 303
|
2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide
|
878489-28-2
|
SC-1
|
SC-1
|
1313019-65-6
|
LUN09945
|
化合物RET V804M-IN-1
|
2414909-94-5
|
3-(4-Methoxyphenyl)-N-(2-morpholinopyrimidin-4-yl)isoxazol-5-amine
|
BO-264
|
2408648-20-2
|
EGFR Inhibitor
|
EGFR INHIBITOR
|
879127-07-8
|
STING agonist-1
|
702662-50-8
|
702662-50-8
|
BZAD01
|
BZAD01
|
305339-41-7
|
MAC-545496
|
MAC-545496
|
838810-96-1
|
TH 257
|
TH-257
|
2244678-29-1
|
CDN1163
|
4-異丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺
|
892711-75-0
|
Pbt-1033
|
化合物PBT-1033
|
747408-78-2
|
163239-22-3
|
680C91
|
163239-22-3
|
Sotrastaurin (AEB071)
|
3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮
|
425637-18-9
|
RAF709
|
化合物RAF709
|
1628838-42-5
|
AIM-100
|
5,6-二苯基-N-[[(2S)-四氫-2-呋喃基]甲基]呋喃并[2,3-D]嘧啶-4-胺
|
873305-35-2
|
EZH2-IN-2
|
EZH2-A€IN-A€2
|
2238821-31-1
|
ATP synthase inhibitor 1
|
ATP SYNTHASE INHIBITOR 1
|
1023043-30-2
|
THPP-1
|
THPP-1
|
1257051-63-0
|
Mebeverine alcohol
|
酒美貝維林
|
14367-47-6
|
SC-26196
|
ALPHA,ALPHA-二苯基-4-[(3-吡啶亞甲基)氨基]-1-吡嗪戊腈
|
218136-59-5
|
TCS PIM-1 1
|
TCS PIM-1 1
|
491871-58-0
|
PLpro inhibitor
|
5-(乙酰氨基)-2-甲基-N-[(1R)-1-(1-萘基)乙基]苯甲酰胺
|
1093070-14-4
|
INK-1117 MLN1117
|
6-(2-氨基-5-苯并惡唑基)咪唑并[1,2-A]吡啶-3-基]-4-嗎啉基甲酮
|
1268454-23-4
|
ML-327
|
1883510-31-3
|
1883510-31-3
|
RL 0617
|
5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide
|
1093070-16-6
|
NF-2
|
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
|
778270-11-4
|